Kansas Bioscience Authority

Flow Forward Medical is a company focused on developing vascular access solutions to enhance post-surgery success rates. Its primary product, the Arteriovenous Fistula Eligibility (AFE) System, is a small, temporary external blood pump engineered to promote flow-mediated dilation of veins. This innovation aims to increase the eligibility of patients for arteriovenous fistula (AVF) procedures, which are critical for hemodialysis patients. By improving the establishment of reliable AVFs, Flow Forward Medical seeks to reduce both morbidity and mortality among these patients, while also lowering overall healthcare costs. Founded in 2014 by Frank Nicholas Franano, the company is based in Olathe, Kansas.

Innara Health, Inc. specializes in developing neonatal care technologies aimed at improving the health and development outcomes for preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device that supports the development of non-nutritive sucking skills in newborns, which is crucial for feeding. This system assists caregivers in neonatal and pediatric intensive care units by providing insights into effective treatment strategies for infants facing feeding challenges. Founded in 2006 and based in Olathe, Kansas, Innara Health was previously known as KCBioMedix, Inc. until it rebranded in 2013. The company’s innovations are focused on enhancing the quality of life for infants and their families, as well as improving overall feeding outcomes in hospital settings.

Artio Medical, Inc. is a medical device company focused on developing and commercializing catheter-based solutions for cardiovascular diseases. Based in Olathe, Kansas, the company specializes in endovascular devices designed for embolization of vessels, aneurysms, and other vascular structures. Its product offerings include Solus Gold and Solus Flex, both embolization devices featuring unique delivery systems, as well as Aneura and Endura, which combine coils and accessory balloons for the immediate occlusion of saccular and cerebral aneurysms, respectively. Artio Medical was founded in 2011 and was previously known as Metactive Medical, Inc. before rebranding in February 2020. The company operates as a subsidiary of Novita Therapeutics, LLC, and its innovations aim to enhance the speed and safety of vascular occlusion procedures for physicians.

Flow Forward Medical is a company focused on developing vascular access solutions to enhance post-surgery success rates. Its primary product, the Arteriovenous Fistula Eligibility (AFE) System, is a small, temporary external blood pump engineered to promote flow-mediated dilation of veins. This innovation aims to increase the eligibility of patients for arteriovenous fistula (AVF) procedures, which are critical for hemodialysis patients. By improving the establishment of reliable AVFs, Flow Forward Medical seeks to reduce both morbidity and mortality among these patients, while also lowering overall healthcare costs. Founded in 2014 by Frank Nicholas Franano, the company is based in Olathe, Kansas.

Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutics for dogs and cats in the United States. Founded in 2010 and headquartered in Leawood, Kansas, the company focuses on addressing unmet medical needs in companion animal care through high-quality medicines. Its product portfolio includes various therapeutics, such as NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for pain and inflammation associated with osteoarthritis. Aratana is also advancing treatments for conditions like osteosarcoma in dogs and a range of therapies for cats, including a specialized formulation for pain management and treatments for feline herpes virus-induced conditions. The company has established collaboration agreements with other health organizations to enhance the development and commercialization of its products.

Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutics for dogs and cats in the United States. Founded in 2010 and headquartered in Leawood, Kansas, the company focuses on addressing unmet medical needs in companion animal care through high-quality medicines. Its product portfolio includes various therapeutics, such as NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for pain and inflammation associated with osteoarthritis. Aratana is also advancing treatments for conditions like osteosarcoma in dogs and a range of therapies for cats, including a specialized formulation for pain management and treatments for feline herpes virus-induced conditions. The company has established collaboration agreements with other health organizations to enhance the development and commercialization of its products.

Innara Health, Inc. specializes in developing neonatal care technologies aimed at improving the health and development outcomes for preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device that supports the development of non-nutritive sucking skills in newborns, which is crucial for feeding. This system assists caregivers in neonatal and pediatric intensive care units by providing insights into effective treatment strategies for infants facing feeding challenges. Founded in 2006 and based in Olathe, Kansas, Innara Health was previously known as KCBioMedix, Inc. until it rebranded in 2013. The company’s innovations are focused on enhancing the quality of life for infants and their families, as well as improving overall feeding outcomes in hospital settings.